Xiaoxiang Chen
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 12, 2023
Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study.Xinyi Hong, Shanhu Qiu, Xia Wu
|Aug 09, 2022
Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient: a Case Report.Qian Zhao, Jing Ni, Jiayin Dong
|May 17, 2021
The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China.Jing Ni, Xianzhong Cheng, Qian Zhao
|Nov 11, 2020
Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer.Jing Ni, Yan Wang, Xianzhong Cheng
|Jun 18, 2020
The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial.Hongyuan Gu, Rui Zhou, Jing Ni
|Nov 29, 2019
Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China.Jing Ni, Xianzhong Cheng, Rui Zhou
Pageof 1
